Published in Am J Pathol on May 01, 1996
Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide. Proc Natl Acad Sci U S A (1996) 1.31
p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells. Am J Pathol (2001) 1.10
Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer. Br J Cancer (2000) 1.09
p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance. Front Oncol (2012) 1.04
MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63. Oncogene (2011) 1.02
Ubiquitous induction of p53 in tumor cells by antisense inhibition of MDM2 expression. Mol Med (1999) 1.00
USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis. Cell Death Dis (2013) 0.96
Genetic analysis of p53 nuclear importation. Oncogene (2007) 0.95
Therapeutic targets for neuroblastomas. Expert Opin Ther Targets (2014) 0.87
Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells. Cancer Chemother Pharmacol (2008) 0.84
Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma. Mol Cancer Ther (2009) 0.83
P53 is transported into the nucleus via an Hsf1-dependent nuclear localization mechanism. Mol Carcinog (2010) 0.79
Loss of HSF1 results in defective radiation-induced G(2) arrest and DNA repair. Radiat Res (2011) 0.78
Induction of apoptosis by cytoplasmically localized wild-type p53 and the S121F mutant super p53. Oncol Lett (2012) 0.77
Effect of low doses of actinomycin D on neuroblastoma cell lines. Mol Cancer (2016) 0.76
TBP-like protein (TLP) disrupts the p53-MDM2 interaction and induces long-lasting p53 activation. J Biol Chem (2017) 0.75
Ribosomopathy-like properties of murine and human cancers. PLoS One (2017) 0.75
p53 mutations in human cancers. Science (1991) 31.96
Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A (1992) 8.87
Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J (1994) 6.83
p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell (1994) 3.69
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A (1992) 3.27
Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci U S A (1995) 2.56
The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res (1994) 2.41
P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev (1995) 1.92
Absence of p53 gene mutations in primary neuroblastomas. Cancer Res (1993) 1.69
Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res (1991) 1.49
Low frequency of the p53 gene mutations in neuroblastoma. Cancer (1994) 1.33
Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res (1993) 1.26
Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-1 human myeloid leukemia cells. Cell Growth Differ (1993) 1.21
No TP53 mutations in neuroblastomas detected by PCR-SSCP analysis. Genes Chromosomes Cancer (1994) 0.85
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (1998) 11.90
Cell cycle control and cancer. Science (1994) 10.90
Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A (1992) 8.87
The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev (1998) 7.46
RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J (1998) 6.68
Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem (1999) 6.14
Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science (1994) 6.11
DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev (1997) 5.76
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature (2000) 5.55
The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J (1999) 5.47
Neurologic complications in children with enterovirus 71 infection. N Engl J Med (1999) 5.22
Biological basket weaving: formation and function of clathrin-coated vesicles. Annu Rev Cell Dev Biol (2001) 4.72
Conversion of Bcl-2 to a Bax-like death effector by caspases. Science (1997) 4.55
The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo. Mol Cancer Ther (2001) 4.37
Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol (2001) 4.35
DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol (1994) 4.14
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev (2001) 4.06
Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev (1999) 3.59
Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol Cell Biol (1997) 3.54
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci U S A (1993) 3.32
Postoperative analgesia for shoulder surgery: a critical appraisal and review of current techniques. Anaesthesia (2010) 3.25
Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature (1997) 2.98
A mechanism for translationally coupled mRNA turnover: interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex. Cell (2000) 2.83
Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. EMBO J (1987) 2.67
The primary structure of the Saccharomyces cerevisiae gene for 3-phosphoglycerate kinase. Nucleic Acids Res (1982) 2.67
p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci U S A (1994) 2.63
Isolation and genetic localization of three phi-X174 promoter regions. Nat New Biol (1973) 2.55
New tests for syphilis: rational design of a PCR method for detection of Treponema pallidum in clinical specimens using unique regions of the DNA polymerase I gene. J Clin Microbiol (2001) 2.50
Replication focus-forming activity 1 and the Werner syndrome gene product. Nat Genet (1998) 2.47
Molecular subtyping of Treponema pallidum subspecies pallidum. Sex Transm Dis (1998) 2.44
Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci U S A (1998) 2.42
The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res (1994) 2.41
U-rich sequence-binding proteins (URBPs) interacting with a 20-nucleotide U-rich sequence in the 3' untranslated region of c-fos mRNA may be involved in the first step of c-fos mRNA degradation. Mol Cell Biol (1992) 2.40
Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem (1996) 2.39
Rous sarcoma virus transforming protein, p60src, expressed in E. coli, functions as a protein kinase. Nature (1981) 2.37
ARF is required for maintenance of yeast Golgi and endosome structure and function. Mol Biol Cell (1998) 2.32
A broader role for AU-rich element-mediated mRNA turnover revealed by a new transcriptional pulse strategy. Nucleic Acids Res (1998) 2.31
Development of anti-pp60src serum with antigen produced in Escherichia coli. J Virol (1983) 2.26
Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev (1995) 2.17
Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol (2000) 2.17
Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J Infect Dis (1996) 2.12
Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem (1999) 2.12
The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer. Cancer Res (2001) 2.06
ATM: genome stability, neuronal development, and cancer cross paths. Adv Cancer Res (2001) 2.05
GATA-4 and Nkx-2.5 coactivate Nkx-2 DNA binding targets: role for regulating early cardiac gene expression. Mol Cell Biol (1998) 2.00
Fragments of ATM which have dominant-negative or complementing activity. Mol Cell Biol (1997) 1.99
Assessment of epidermal growth factor receptor (EGFR, ErbB1) and HER2 (ErbB2) protein expression levels and response to lapatinib (Tykerb, GW572016) in an expanded panel of human normal and tumour cell lines. Cell Prolif (2007) 1.99
SlyA, a transcriptional regulator of Salmonella typhimurium, is required for resistance to oxidative stress and is expressed in the intracellular environment of macrophages. Infect Immun (1997) 1.94
Involvement of pp60c-src with two major signaling pathways in human breast cancer. Proc Natl Acad Sci U S A (1994) 1.94
Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res (1993) 1.92
Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol Cell Biol (2001) 1.92
The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res (2001) 1.90
Functional characterization of a non-AUUUA AU-rich element from the c-jun proto-oncogene mRNA: evidence for a novel class of AU-rich elements. Mol Cell Biol (1996) 1.90
Multiple elements in the c-fos protein-coding region facilitate mRNA deadenylation and decay by a mechanism coupled to translation. J Biol Chem (1994) 1.90
Pyogenic liver abscess in Taiwan: emphasis on gas-forming liver abscess in diabetics. Am J Gastroenterol (1993) 1.84
The ATM-dependent DNA damage signaling pathway. Cold Spring Harb Symp Quant Biol (2005) 1.83
Molecular cloning of avian sarcoma virus closed circular DNA: structural and biological characterization of three recombinant clones. J Virol (1980) 1.80
Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95. Oncogene Res (1988) 1.79
Identification and cloning of a fur homolog from Neisseria gonorrhoeae. Infect Immun (1993) 1.78
The role of health risk factors and disease on worker productivity. J Occup Environ Med (1999) 1.78
p53 and ATM: cell cycle, cell death, and cancer. Adv Cancer Res (1997) 1.77
Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. Eur Heart J (1995) 1.76
Induction of gene amplification by arsenic. Science (1988) 1.72
Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment. Am J Gastroenterol (1996) 1.71
The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium. Mol Cell Biol (1996) 1.67
Chancroid, primary syphilis, genital herpes, and lymphogranuloma venereum in Antananarivo, Madagascar. J Infect Dis (1999) 1.64
Transcriptional pulsing approaches for analysis of mRNA turnover in mammalian cells. Methods (1999) 1.64
Tumor-suppressor p53: implications for tumor development and prognosis. J Clin Oncol (1998) 1.63
ATM binds to beta-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci U S A (1998) 1.63
Construction of plasmids for expression of Rous sarcoma virus transforming protein, p60src, in Escherichia coli. Proc Natl Acad Sci U S A (1982) 1.63
Saccharomyces cerevisiae PKC1 encodes a protein kinase C (PKC) homolog with a substrate specificity similar to that of mammalian PKC. J Biol Chem (1994) 1.62
Gas in hepatic veins: a rare and critical presentation of emphysematous pyelonephritis. J Urol (1994) 1.60
Ionizing radiation activates the ATM kinase throughout the cell cycle. Oncogene (2000) 1.60
Dissecting the protein kinase C/MAP kinase signalling pathway of Saccharomyces cerevisiae. Cell Mol Biol Res (1994) 1.59
Visual arrestin binding to rhodopsin. Intramolecular interaction between the basic N terminus and acidic C terminus of arrestin may regulate binding selectivity. J Biol Chem (1994) 1.59
Melatonin prevents pigment gallstone formation induced by bile duct ligation in guinea pigs. Hepatology (2000) 1.58
Molecular typing of Treponema pallidum in South Africa: cross-sectional studies. J Clin Microbiol (2002) 1.56
Spontaneous rupture of hepatocellular carcinoma. A review of 141 Taiwanese cases and comparison with nonrupture cases. J Clin Gastroenterol (1995) 1.55
Video-assisted thoracoscopic T2 sympathectomy for hyperhidrosis palmaris. J Am Coll Surg (1994) 1.54
Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci U S A (1994) 1.53
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant (1998) 1.51
The association between Helicobacter pylori infection and functional dyspepsia in patients with irritable bowel syndrome. Am J Gastroenterol (2000) 1.50
Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol Psychiatry (2010) 1.49
Gastrointestinal tract involvement in hepatocellular carcinoma: clinical, radiological and endoscopic studies. Endoscopy (1990) 1.49
CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci U S A (1991) 1.47
In vitro elution of antibiotic from antibiotic-impregnated biodegradable calcium alginate wound dressing. J Trauma (1999) 1.47
Identification of multiple nuclear factors that interact with cyclic adenosine 3',5'-monophosphate response element-binding protein and activating transcription factor-2 by protein-protein interactions. Mol Endocrinol (1991) 1.46
InGaN self-assembled quantum dots grown by metal-organic chemical vapour deposition with growth interruption. Nanotechnology (2006) 1.45
Unique chromosomal rearrangement and mucin production in a novel salivary myoepithelial cell strain. Arch Otolaryngol Head Neck Surg (1993) 1.41
The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects. J Infect Dis (1998) 1.40
Nonrandom loss of chromosome 15 in Syrian hamster tumours induced by v-Ha-ras plus v-myc oncogenes. Nature (1985) 1.39
Expression of hepatitis B virus surface antigen in yeast. Nucleic Acids Res (1983) 1.39
Review of telemedicine projects in Taiwan. Int J Med Inform (2001) 1.38
The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor. Proc Natl Acad Sci U S A (1993) 1.36